Home / health news / $0.73 EPS Expected For Bristol-Myers Squibb Company (NYSE:BMY) In Quarter quoting : themarketsdaily
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

$0.73 EPS Expected For Bristol-Myers Squibb Company (NYSE:BMY) In Quarter quoting : themarketsdaily

according to Analysts on the Street are predicting that Bristol-Myers Squibb Company (NYSE:BMY) will report earnings of $0.73 per share for the current fiscal quarter.
Most recently Bristol-Myers Squibb Company (NYSE:BMY) reported earnings per share of $0.63 for the fiscal period ended on 2016-12-31.
Bristol-Myers Squibb Company (NYSE:BMY) currently has an ABR of 2.35 based on 11 research analysts providing projections.
The most bearish analyst has the price target set at $42 of Bristol-Myers Squibb Company (NYSE:BMY) for the same one year time frame.
Looking further ahead at the long term growth projections for the company, analysts are anticipating earnings per share of $2.8 for the current year.

$0.73 EPS Expected For Bristol-Myers Squibb Company (NYSE:BMY) In Quarter

As it stated in Bristol-Myers (NYSE:BMY) has activist investor Barry Rosenstein and his JANA Partners as a shareholder.
Part of the troubles has been getting Opdivo past trials for lung cancer, which is weighing on the company.
The best move for JANA or another activist would be to force Bristol-Myers to diversify its product portfolio.
Instead, Bristol-Myers, the $80 billion market cap pharma company, should merge with the likes of Pfizer (NYSE:PFE) – which has been on the prowl for a mega-deal.
So while its patent losses are troubling, Bristol-Myers’ new drugs could more than offset these losses.

As it stated in

Bristol-Myers Squibb Company (NYSE:BMY) EPS Projection At $0.865

Bristol-Myers Squibb Company (NYSE:BMY) is anticipated to account earnings of $0.865 for its recent quarter.
Sentiment score of 0.134 has been publicized by Alpha One for Bristol-Myers Squibb Company (NYSE:BMY).
Bristol-Myers Squibb Company posted EPS of $0.63 for quarter closed on 2016-12-31.
Bristol-Myers Squibb Company (NYSE:BMY) impact score is 84 on 1-100 base.
Zacks has allotted ABR of 2.35 for Bristol-Myers Squibb Company equity against the grade of 2.35 a quarter before.

about the details read more from here

This content may collect you by Luaren Colin

To follow all the new news about health

Check Also

picture.jpg

A new recommendation to reduce the number of shots for children of HPV vaccine

according to “This vaccine should have been introduced as a vaccine that will prevent cancer, …